Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Intravenous GLutamine Supplementation IN Trauma Patients Receiving Enteral Nutrition Study Protocol (GLINT Study): A Prospective, Blinded, Randomized, Placebo-controlled Clinical Trial

NCT01240291 is registered in ClinicalTrials.gov with Royal Brisbane and Women's Hospital as lead sponsor.

NCT NCT01240291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01240291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Intravenous GLutamine Supplementation IN Trauma Patients Receiving Enteral Nutrition Study Protocol (GLINT Study): A Prospective, Blinded, Randomized, Placebo-controlled Clinical Trial
Lead sponsor
Royal Brisbane and Women's Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2011
Completion date
June 30, 2013
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill, multiple trauma